BR0214196A - Método e composição para reduzir a atividade de inibir o crescimento de uma célula cancerosa, para tratar de paciente com câncer - Google Patents

Método e composição para reduzir a atividade de inibir o crescimento de uma célula cancerosa, para tratar de paciente com câncer

Info

Publication number
BR0214196A
BR0214196A BR0214196-5A BR0214196A BR0214196A BR 0214196 A BR0214196 A BR 0214196A BR 0214196 A BR0214196 A BR 0214196A BR 0214196 A BR0214196 A BR 0214196A
Authority
BR
Brazil
Prior art keywords
composition
reducing
treat
cancer
cancer cell
Prior art date
Application number
BR0214196-5A
Other languages
English (en)
Inventor
Yoav Sharoni
Joseph Levy
Original Assignee
Lycored Natural Prod Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lycored Natural Prod Ind Ltd filed Critical Lycored Natural Prod Ind Ltd
Publication of BR0214196A publication Critical patent/BR0214196A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"MéTODO E COMPOSIçãO PARA REDUZIR A ATIVIDADE E INIBIR O CRESCIMENTO DE UMA CéLULA CANCEROSA, PARA TRATAR DE PACIENTE COM CâNCER". Método para reduzir a atividade de uma célula cancerosa, compreendendo administrar a um indivíduo necessitado da mesma, uma composição compreendendo licopeno e um carotenóide adicional.
BR0214196-5A 2001-11-12 2002-11-05 Método e composição para reduzir a atividade de inibir o crescimento de uma célula cancerosa, para tratar de paciente com câncer BR0214196A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL14644901A IL146449A0 (en) 2001-11-12 2001-11-12 Method and pharmaceutical preparations for reducing the activity of cells
PCT/IL2002/000876 WO2003041695A1 (en) 2001-11-12 2002-11-05 Method and pharmaceutical preparations for reducing the activity of cells

Publications (1)

Publication Number Publication Date
BR0214196A true BR0214196A (pt) 2004-08-31

Family

ID=11075857

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214196-5A BR0214196A (pt) 2001-11-12 2002-11-05 Método e composição para reduzir a atividade de inibir o crescimento de uma célula cancerosa, para tratar de paciente com câncer

Country Status (13)

Country Link
US (1) US20040259959A1 (pt)
EP (1) EP1443914A1 (pt)
JP (1) JP2005513009A (pt)
KR (1) KR20050043784A (pt)
CN (1) CN100408030C (pt)
BR (1) BR0214196A (pt)
CA (1) CA2466508A1 (pt)
IL (1) IL146449A0 (pt)
NO (1) NO20041773L (pt)
PL (1) PL368857A1 (pt)
RU (1) RU2004114282A (pt)
WO (1) WO2003041695A1 (pt)
ZA (1) ZA200403482B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006008714A (ja) * 2005-03-17 2006-01-12 Yamaha Motor Co Ltd マトリックスメタロプロテイナーゼ阻害剤
ES2546484T3 (es) 2005-03-18 2015-09-24 Dsm Ip Assets B.V. Producción de carotenoides en levadura y hongos oleaginosos
JP2006008718A (ja) * 2005-06-03 2006-01-12 Yamaha Motor Co Ltd シクロオキシゲナーゼ活性阻害剤
JP2006008719A (ja) * 2005-06-23 2006-01-12 Yamaha Motor Co Ltd 血中過酸化脂質抑制剤
WO2008042338A2 (en) 2006-09-28 2008-04-10 Microbia, Inc. Production of carotenoids in oleaginous yeast and fungi
CN105193777B (zh) * 2009-01-19 2019-06-28 利科雷德有限公司 类胡萝卜素和多酚的协同组合
PL2441433T3 (pl) * 2010-10-13 2016-10-31 Olleya marilimosa i ich zastosowanie w sposobie wytwarzania kompozycji zawierającej zeaksantynę
US20130302319A1 (en) * 2012-05-09 2013-11-14 The New York Eye And Ear Infirmary Zeaxanthin for tumor treatment
CN105324114B (zh) * 2013-03-19 2018-01-30 乐康瑞德有限公司 虾青素抗炎增效组合
EP3030648B1 (en) 2013-08-08 2020-01-08 Knipbio, Inc. Methylotrophs for aquaculture and animal feed
MX2016007340A (es) 2013-12-06 2016-12-14 Dsm Ip Assets Bv Formulacion de biomasa.
EP3153160B1 (en) * 2015-10-08 2021-08-11 Chuen Wei Lu Use of xanthophylls for the treatment of cancers
US9572783B1 (en) * 2015-10-08 2017-02-21 Chuen Wei Lu Use of xanthophylls for the treatment of cancers
CN107049998A (zh) * 2016-09-20 2017-08-18 南华大学附属第二医院 番茄红素顺式异构体在制备卵巢癌治疗药物中的应用
IT201700005649A1 (it) 2017-01-19 2018-07-19 Associazione Oncologica Milanese Amo La Vita Onlus Uso di derivati di carotenoidi per ridurre la tossicità ed aumentare l’efficacia di trattamenti antitumorali anti-egfr

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103920A (en) * 1992-11-30 2000-07-26 Makhteshim Chem Works Ltd Pharmaceutical preparations for inhibiting the growth of cancer cells and use of lycopene for the preparation thereof
US5643623A (en) * 1995-06-07 1997-07-01 Mars Incorporated Health food product and its uses
AUPO693397A0 (en) * 1997-05-22 1997-06-12 Betatene Limited Carotenoid formulation
DE19838636A1 (de) * 1998-08-26 2000-03-02 Basf Ag Carotinoid-Formulierungen, enthaltend ein Gemisch aus beta-Carotin, Lycopin und Lutein
EP0984059A1 (en) * 1998-09-01 2000-03-08 The Procter & Gamble Company Bleaching compositions
AU1135701A (en) * 1999-10-14 2001-04-23 Schroeder, Fritz H. Compositions with anti-prostate cancer activity
IL135335A (en) * 2000-03-29 2013-12-31 Lycored Natural Prod Ind Ltd Use of Carotenoids in Preparing Pharmaceuticals to Prevent Adverse Effects from Hormones and Pharmaceuticals Containing Carotenoids

Also Published As

Publication number Publication date
CN100408030C (zh) 2008-08-06
JP2005513009A (ja) 2005-05-12
IL146449A0 (en) 2002-07-25
NO20041773L (no) 2004-06-29
PL368857A1 (en) 2005-04-04
WO2003041695A1 (en) 2003-05-22
US20040259959A1 (en) 2004-12-23
RU2004114282A (ru) 2005-03-20
KR20050043784A (ko) 2005-05-11
CA2466508A1 (en) 2003-05-22
ZA200403482B (en) 2005-07-25
EP1443914A1 (en) 2004-08-11
CN1612728A (zh) 2005-05-04

Similar Documents

Publication Publication Date Title
BR0214196A (pt) Método e composição para reduzir a atividade de inibir o crescimento de uma célula cancerosa, para tratar de paciente com câncer
ATE496643T1 (de) Verwendung von antioxidantien zur verhinderung von oxidation und zur reduzierung von wirkstoffzersetzung in wirkstoffhaltigen medizinischen artikeln
CY1116463T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
TR201903587T4 (tr) Telomeraz aktivitesinin artırılması için bileşimler.
BR0107705A (pt) Uso de uma alìquota de sangue modificado em um paciente para tratamento de falência cardìaca congestiva
BR0308854A (pt) Benzazolas substituìdas e seus usos como inibidoras de quinase raf
TR200201442T2 (tr) Ağrı hafifletme, kemik kanseri terapisi ve kemik yüzeyinin sağlıklı tutulması için kireçlenmiş hedef dokulara yönelik radyum-223 hazırlanması ve kullanımı.
BR0013065A (pt) Método e composto para tratar de uma doença associada com recrutamento e/ ou ativação aberrante de leucócitos
ATE332136T1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
BRPI0413574A (pt) aplicação de polipeptìdeos da famìlia cupredoxina na terapia do cáncer
BRPI0418157A (pt) terapêutica de tumores alogênicos
DE50014532D1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
BRPI0407611A (pt) agente anti-cáncer compreendendo proteìna lk8 como um ingrediente ativo
SE0102147D0 (sv) New methods
RS52011B (sr) Nova primena derivata taksoida
HK1037980A1 (en) Use of selegiline or desmethylselegiline for the manufacture of a medicament for treating wounds, burns or photodamage.
AP2004003177A0 (en) Composition and its therapeutic use
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
AU3401093A (en) Therapeutic agent for threatened abortion
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
ATE345805T1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
SI1596879T1 (sl) Uporaba spojine kahalalida za pripravo zdravila za zdravljenje luskavice
AU6432899A (en) Use of metformin to counteract weight gain associated with valproate and other psychotropic medications
DE60036725D1 (de) Zusammensetzungen enthaltend vernix und ein uv-schutzmittel, und deren verwendung
MXPA03011186A (es) Uso de pentraxina ptx3 de cadena larga para tratamiento contra enfermedades tumorales mediadas por fgf-8.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2064 DE 27/07/2010.